|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
|
US6699497B1
(en)
*
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
|
JP4198318B2
(ja)
|
1998-08-19 |
2008-12-17 |
ヤーゴテック アクチェンゲゼルシャフト |
プロポフォールの注射可能水性分散物
|
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
|
HUP0104728A3
(en)
*
|
1998-12-18 |
2006-07-28 |
Alza Corp Mountain View |
Transparent transdermal nicotine delivery device
|
|
AU3536799A
(en)
*
|
1999-04-26 |
2000-11-10 |
Lead Chemical Co., Ltd. |
Percutaneous preparations containing oxybutynin
|
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
|
US6562368B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
|
US6957924B1
(en)
|
2000-02-14 |
2005-10-25 |
Johnson & Johnson Consumer Companies, Inc. |
Textured film devices
|
|
US6607739B1
(en)
|
2000-02-14 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Dispensing article
|
|
US6783294B2
(en)
|
2000-02-14 |
2004-08-31 |
Johnson & Johnson Consumer Companies, Inc. |
Solid cleanser holder
|
|
US6436428B1
(en)
|
2000-03-21 |
2002-08-20 |
Enhance Pharmaceuticals, Inc. |
Device and method for treating urinary incontinence in females
|
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
CN1438861A
(zh)
*
|
2000-04-26 |
2003-08-27 |
沃特森药物公司 |
最小化与奥昔布宁疗法有关的副作用
|
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
|
CN1250206C
(zh)
*
|
2001-03-07 |
2006-04-12 |
久光制药株式会社 |
贴剂
|
|
DE10237057A1
(de)
*
|
2002-08-09 |
2004-03-25 |
Grünenthal GmbH |
Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
|
|
JP4354678B2
(ja)
*
|
2002-08-28 |
2009-10-28 |
久光製薬株式会社 |
貼付剤
|
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
|
ES2258694T3
(es)
|
2003-11-11 |
2006-09-01 |
Mattern, Udo |
Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
|
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
|
US20050234024A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Clarke David E |
Materials and methods for the treatment of ulcerative colitis
|
|
JP2005325165A
(ja)
*
|
2004-05-12 |
2005-11-24 |
Three M Innovative Properties Co |
１００℃以下の温度で溶融塗布可能なヨウ素含有ホットメルト粘着剤および該粘着剤を用いた医療用粘着シート製品
|
|
US20070082039A1
(en)
*
|
2004-10-18 |
2007-04-12 |
Jones Gerald S Jr |
Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids
|
|
ATE471146T1
(de)
|
2004-10-21 |
2010-07-15 |
Durect Corp |
Transdermale verabreichungssysteme
|
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
CN101340884A
(zh)
|
2005-10-19 |
2009-01-07 |
曼尼·马纳舍·辛格尔 |
用于治疗多汗症的方法
|
|
EP1986618A2
(en)
*
|
2006-02-13 |
2008-11-05 |
Aveva Drug Delivery Systems, Inc. |
Adhesive preparation comprising sufentanil and methods of using the same
|
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
WO2007129427A1
(ja)
*
|
2006-05-08 |
2007-11-15 |
Teikoku Seiyaku Co., Ltd. |
抗認知症薬物の経皮吸収製剤
|
|
KR20090021169A
(ko)
*
|
2006-05-16 |
2009-02-27 |
크놉 뉴로사이언시스 인코포레이티드 |
Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
|
|
CA2664427C
(en)
|
2006-10-04 |
2012-06-05 |
M & P Patent Aktiengesellschaft |
Controlled release delivery system for nasal application of neurotransmitters
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
CN101715443A
(zh)
|
2007-03-14 |
2010-05-26 |
诺普神经科学股份有限公司 |
手性纯化的取代的苯并噻唑二胺的合成
|
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
|
WO2010039381A1
(en)
*
|
2008-09-30 |
2010-04-08 |
Teikoku Pharma Usa, Inc. |
Transdermal extended-delivery donepezil compositions and methods for using the same
|
|
EP2355806A2
(en)
*
|
2008-11-14 |
2011-08-17 |
Profimed s.r.o. |
Non-aqueous colloidal formulation
|
|
US8920392B2
(en)
|
2009-05-05 |
2014-12-30 |
Watson Laboratories, Inc. |
Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
|
DE102009022915A1
(de)
*
|
2009-05-27 |
2010-12-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
|
|
CN102802418A
(zh)
*
|
2009-06-19 |
2012-11-28 |
诺普神经科学股份有限公司 |
用于治疗肌萎缩性侧索硬化的组合物和方法
|
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
|
JP6527305B2
(ja)
|
2011-01-10 |
2019-06-05 |
インヴィオン， インコーポレイテッド |
禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
|
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
|
TW201338813A
(zh)
*
|
2011-12-12 |
2013-10-01 |
洛曼治療系統股份有限公司 |
經皮遞送系統
|
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
|
US9074972B2
(en)
|
2012-05-16 |
2015-07-07 |
Dionex Corporation |
Surrogate addition device and a method of analyte concentration
|
|
CN103919754B
(zh)
*
|
2013-01-15 |
2018-11-06 |
江苏康倍得药业股份有限公司 |
奥昔布宁药物组合物及其应用
|
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
|
ES2699257T3
(es)
|
2013-02-28 |
2019-02-08 |
Dermira Inc |
Sales de glicopirrolato
|
|
US9006462B2
(en)
|
2013-02-28 |
2015-04-14 |
Dermira, Inc. |
Glycopyrrolate salts
|
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
|
WO2014188329A2
(en)
|
2013-05-20 |
2014-11-27 |
Mylan, Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
|
ES3043076T3
(en)
|
2013-07-12 |
2025-11-24 |
Areteia Therapeutics Inc |
Treating elevated levels of eosinophils and/or basophils
|
|
ES2871556T3
(es)
|
2013-08-13 |
2021-10-29 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de la urticaria crónica
|
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
|
TWI709417B
(zh)
|
2013-10-07 |
2020-11-11 |
美商帝國製藥美國股份有限公司 |
使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
|
|
RU2018105761A
(ru)
*
|
2013-10-07 |
2019-02-26 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Устройства для трансдермальной доставки дексмедетомидина и способы их применения
|
|
RU2648449C2
(ru)
|
2013-10-07 |
2018-03-26 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
|
|
CN104666279A
(zh)
*
|
2013-11-28 |
2015-06-03 |
上海现代药物制剂工程研究中心有限公司 |
载药的三维网状立体构型的透皮给药制剂及其制备方法
|
|
US10149828B2
(en)
|
2015-01-09 |
2018-12-11 |
Chase Pharmaceuticals Corporation |
Oxybutynin transdermal therapeutic system combination
|
|
SG11201805570WA
(en)
|
2015-12-30 |
2018-07-30 |
Corium Int Inc |
Systems and methods for long term transdermal administration
|
|
WO2017223402A1
(en)
|
2016-06-23 |
2017-12-28 |
Corium International, Inc. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
|
US10945968B2
(en)
|
2016-07-27 |
2021-03-16 |
Corium, Inc. |
Memantine transdermal delivery systems
|
|
AU2017301928B2
(en)
*
|
2016-07-27 |
2023-04-06 |
Corium, LLC. |
Donepezil transdermal delivery system
|
|
KR20210113439A
(ko)
|
2016-10-31 |
2021-09-15 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
|
|
ES3065670T3
(en)
|
2017-04-24 |
2026-05-07 |
Alto Neuroscience Inc |
Compositions and method for treating depression
|
|
EP3658127A1
(en)
*
|
2017-07-26 |
2020-06-03 |
Corium, Inc. |
Transdermal delivery system with a microporous membrane having solvent-filled pores
|
|
US11173132B2
(en)
|
2017-12-20 |
2021-11-16 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
|
US20240245892A1
(en)
*
|
2021-10-22 |
2024-07-25 |
Georgetown University |
Non-Invasive and Passive Transdermal Drug Delivery Patch For Parkinson's Disease
|